LXR-623

DRUG3 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer

Conditions

HealthyHealthy Subjects

Phase 1

Study Evaluating LXR-623 in Healthy Subjects

CompletedNCT00366522

Wyeth is now a wholly owned subsidiary of PfizerHealthy

Start: 2006-08-31End: 2006-09-30Updated: 2009-08-07

Study Evaluation LXR-623 in Healthy Adults

TerminatedNCT00379860

Wyeth is now a wholly owned subsidiary of PfizerHealthy Subjects

Start: 2006-10-31End: 2007-01-31Updated: 2007-03-09

Study Evaluating LXR-623 in Healthy Japanese Adults

CompletedNCT00385489

Wyeth is now a wholly owned subsidiary of PfizerHealthy

Start: 2006-08-31End: 2006-09-30Updated: 2009-08-07